Hyperbaric oxygen therapy improves early posttransplant islet function

Pediatric Diabetes

Volumn 11, Issue 7, 2010, Pages 471-478

  Sakata, Naoaki ^a,b   Chan, Nathaniel K ^a   Ostrowski, Robert P ^a   Chrisler, John ^a   Hayes, Pete ^a   Kim, Sonny ^a   Obenaus, Andre ^a   Zhang, John H ^a   Hathout, Eba ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

HBO treatment; HIF 1 ; Islet transplantation; MRI; VEGF

Indexed keywords

BIOLOGICAL MARKER; GADODIAMIDE; GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INSULIN; STREPTOZOCIN; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; AREA UNDER THE CURVE; ARTICLE; BAGG ALBINO MOUSE; CELL DEATH; CELL HYPOXIA; CELL ISOLATION; CELL STIMULATION; CELL VIABILITY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ENGRAFTMENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HISTOPATHOLOGY; HYPERBARIC OXYGEN; HYPOXIA; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; INSULIN RELEASE; MOUSE; NICK END LABELING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PANCREAS ISLET CELL FUNCTION; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOZOCIN DIABETES; THERAPY EFFECT;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; HYPERBARIC OXYGENATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IN SITU NICK-END LABELING; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PHYSIOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77958559746     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2009.00629.x     Document Type: Article

References (33)

1. International Islet Transplant Registry. Newsletter. 2001: 9.
2. Ryan EA, Paty BW, Senior PA et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005: 54: 2060-2069.
3. Shapiro AM, Lakey JR, Ryan EA et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000: 343: 230-238.
4. Yin D, Ding JW, Shen J, Ma L, Hara M, Chong AS. Liver ischemia contributes to early islet failure following intraportal transplantation: benefits of liver ischemic-preconditioning. Am J Transplant 2006: 6: 60-68.
5. Biarnes M, Montolio M, Nacher V, Raurell M, Soler J, Montanya E. Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes 2002: 51: 66-72.
6. Evgenov NV, Medarova Z, Dai G, Bonner-Weir S, Moore A. In vivo imaging of islet transplantation. Nat Med 2006: 12: 144-148.
7. Jirak D, Kriz J, Herynek V et al. MRI of transplanted pancreatic islets. Magn Reson Med 2004: 52: 1228-1233.
8. Hathout E, Sowers L, Wang R et al. In vivo magnetic resonance imaging of vascularization in islet transplantation. Transpl Int 2007: 20: 1059-1065.
9. Hathout E, Chan NK, Tan A et al. In vivo imaging demonstrates a time-line for new vessel formation in islet transplantation. Pediatr Transplant 2009: 13: 892-897.
10. Chan NK, Obenaus A, Tan A et al. Monitoring neovascularization of intraportal islet grafts by dynamic contrast enhanced magnetic resonance imaging. Islets 2009: 1. [Epub ahead of print].
11. Moritz W, Meier F, Stroka DM et al. Apoptosis in hypoxic human pancreatic islets correlates with HIF-1alpha expression. FASEB J 2002: 16: 745-747.
12. Lepore DA, Shinkel TA, Fisicaro N et al. Enhanced expression of glutathione peroxidase protects islet beta cells from hypoxia-reoxygenation. Xenotransplantation 2004: 11: 53-59.
13. Jones GL, Juszczak MT, Hughes SJ, Kooner P, Powis SH, Press M. Time course and quantification of pancreatic islet revascularization following intraportal transplantation. Cell Transplant 2007: 16: 505-516.
14. Miao G, Ostrowski RP, Mace J et al. Dynamic production of hypoxia-inducible factor-1alpha in early transplanted islets. Am J Transplant 2006: 6: 2636-2643.
15. Gotoh M, Maki T, Kiyoizumi T, Satomi S, Monaco AP. An improved method for isolation of mouse pancreatic islets. Transplantation 1985: 40: 437-438.
16. Sakata N, Egawa S, Sumi S, Unno M. Optimization of glucose level to determine the stimulation index of isolated rat islets. Pancreas 2008: 36: 417-423.
17. Yonekawa Y, Okitsu T, Wake K et al. A new mouse model for intraportal islet transplantation with limited hepatic lobe as a graft site. Transplantation 2006: 82: 712-715.
18. Sakata N, Hayes P, Tan A et al. MRI assessment of ischemic liver after intraportal islet transplantation. Transplantation 2009: 87: 825-830.
19. Sakata N, Tan A, Chan N et al. Efficacy comparison between intraportal and subcapsular islet transplants in a murine diabetic model. Transplant Proc 2009: 41: 346-349.
20. Forleo C, Resta N, Sorrentino S et al. Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy. Am J Med 2004: 117: 451-458.
21. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997: 7: 91-101.
22. Muralidharan V, Christophi C. Hyperbaric oxygen therapy and liver transplantation. HPB (Oxford) 2007: 9: 174-182.
23. Menger MD, Jaeger S, Walter P, Feifel G, Hammersen F, Messmer K. Angiogenesis and hemodynamics of microvasculature of transplanted islets of Langerhans. Diabetes 1989: 38 (Suppl. 1): 199-201.
24. Sepulveda P, Martinez-Leon J, Garcia-Verdugo JM. Neoangiogenesis with endothelial precursors for the treatment of ischemia. Transplant Proc 2007: 39: 2089-2094.
25. Milovanova TN, Bhopale VM, Sorokina EM et al. Hyperbaric oxygen stimulates vasculogenic stem cell growth and differentiation in vivo. J Appl Physiol 2009: 106: 711-28.
26. Dai Y, Xu M, Wang Y, Pasha Z, Li T, Ashraf M. HIF-1alpha induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia. J Mol Cell Cardiol 2007: 42: 1036-1044.
27. Greenberg JI, Shields DJ, Barillas SG et al. A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature 2008: 456: 809-813.
28. Ozawa CR, Banfi A, Glazer NL et al. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest 2004: 113: 516-527.
29. Asano T, Kaneko E, Shinozaki S et al. Hyperbaric oxygen induces basic fibroblast growth factor and hepatocyte growth factor expression, and enhances blood perfusion and muscle regeneration in mouse ischemic hind limbs. Circ J 2007: 71: 405-411.
30. Bennet W, Groth CG, Larsson R, Nilsson B, Korsgren O. Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups J Med Sci 2000: 105: 125-133.
31. Johansson H, Lukinius A, Moberg L et al. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 2005: 54: 1755-1762.
32. Sakata N, Obenaus A, Chan N, Mace J, Chinnock R, Hathout E. Factors affecting islet graft embolization in the liver of diabetic mice. Islets 2009: 1: 26-33.
33. Goldstein LJ, Gallagher KA, Bauer SM et al. Endothelial progenitor cell release into circulation is triggered by hyperoxia-induced increases in bone marrow nitric oxide. Stem Cells 2006: 24: 2309-2318.